Ligand Pharmaceuticals | LGND - Stock

Aktienkurs
204.92
Täglich Wechseln
-0.72 -0.35%
Monatlich
-7.38%
Jährlich
96.53%
Q2 Prognose
199.33




Stock Veränderung Datum
Amgen USD 6.22B 121M 2025-12
Anika Therapeutics USD 18.79M 2.5M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
Baxter International USD 2.23B 228M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Enviri Corporation USD 195.42M 360K 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.07M 11.1M 2025-12
Intrexon USD 287K 68K 2022-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Ligand Pharmaceuticals USD 9.13M 2.77M 2025-12
MacroGenics USD 7.91M 840K 2025-12
Merck USD 6.44B 157M 2025-09
Pacira USD 152.86M 4.82M 2025-12
Pfizer USD 11.47B 201M 2025-09
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Veracyte USD 20.55M 219K 2025-12